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Abstract: 
Increased use of gene manipulation in mice (e.g., targeted or random mutagenesis) has been accompanied by 
increased reliance on a very few rapid and simple behavioral assays, each of which aspires to model a human 
behavioral domain. Yet, each assay comprises multiple traits, influenced by multiple genetic factors. Motor 
incoordination (ataxia), a common characteristic of many neurological disorders, may reflect disordered 
balance, muscle strength, proprioception, and/or patterned gait. Impaired motor performance can confound 
interpretation of behavioral assays of learning and memory, exploration, motivation, and sensory competence. 
The rotarod is one of the most commonly used tests to measure coordination in mice. We show here that exactly 
how the rotarod test is performed can markedly alter the apparent patterns of genetic influence both in 
undrugged performance and sensitivity to ethanol intoxication. However, when tested with well chosen 
parameters, the accelerating rotarod test showed very high inter- and intralaboratory reliability. Depending on 
test conditions, ethanol can either disrupt or enhance performance in some strains. Genetic contribution to 
performance on the accelerating versus the fixed-speed rotarod assay can be completely dissociated under some 
test conditions, and multiple test parameters are needed to assess the range of genetic influence adequately. 
 
Article: 
The loss of motor coordination (ataxia) is a common characteristic of many neurological disorders and a 
frequent end-point for studies of drug intoxication. Therefore, behavioral assays that model ataxia are of great 
importance to researchers who are interested in learning more about the mechanisms of drug action and disease. 
One of the most commonly used tests of motor incoordination is the rotarod (1–4), which has two variants: the 
accelerating rotarod (ARR) and the fixed-speed rotarod (FSRR). Studies of inbred strains (5–8), selected lines 
(9), and transgenic animals (10–12) have shown that rotarod performance is highly influenced by genetic 
background in mice. Genetically distinct mice often differ in their undrugged ability to perform, and differ in 
their sensitivities to ethanol and other drugs on the task. 
 
Although the rotarod is widely used in biomedical research, there is little consensus on the ideal parameters and 
test schedules to produce optimal results. We have recently completed studies in genetically heterogeneous 
mice examining the influence of different rod diameters, rotation rate, and training regimens on rotarod 
performance, as well as their effects on sensitivity to ethanol intoxication. We obtained some expected results 
(e.g., training on the ARR improved performance, and performance was influenced by acceleration rate). More 
surprisingly, we found that higher acceleration rates suppressed sensitivity to ethanol intoxication. We also 
found that rod diameter did not markedly affect performance, provided that the diameter was large enough to 
prevent passive rotation on the rod (13). 
 
Many researchers appear to design behavioral studies by simply adopting an apparatus and test strategy from 
the literature, without considering the potential effects of different apparatus and testing protocols. For genetic 
studies, this may be a risky approach, because genotypes may perform well under some test conditions and 
poorly under others. Because researchers often do not know whether the specific test parameters they adopt are 
appropriate or ideal for their particular genotypes, it is difficult to interpret the results of a comparison between 
null mutant and wild-type mice that is restricted to a single test or condition. For example, mice with a null 
mutation for the serotonin 1B receptor subtype gene were less sensitive to ethanol than the 129 strain wild type 
when using two assays of intoxication (grid test and balance beam), but did not differ from wild type in 
sensitivity when using several other behavioral assays, including the ARR and FSRR (14). To assess the 
performance of genetically modified mice adequately, systematic data on a range of common background 
genotypes are needed, surveyed over different apparatus and test conditions. We studied inbred strains of mice 
on both the FSRR and the ARR and estimated their genetic codetermination. Because high intralaboratory 
reliability does not necessarily predict reliability across laboratories (15), we provide data on both intra- and 
interlaboratory reliability of ARR performance and report that apparent strain sensitivity to ethanol intoxication, 
and even the direction of the effects, depends markedly on how the tests are performed. 
 
Materials and Methods 
Rotarod. The AccuRotor Rota Rod (Accuscan Instruments, Columbus, OH) was used for both ARR and FSRR 
tests. The modified apparatus had a 63-cm fall height. Dowel surfaces were covered with 320 grit wet/dry 
sandpaper to provide a uniform surface and to reduce slipping. Starting at 0 rpm, the ARR was accelerated at a 
constant rate of 20–60 rpm/min (99.9 rpm maximum speed). The FSRR rotated at 3, 6.5, or 10 rpm. 
 
ARR. Eight inbred strains (129S1/SvImJ, A/J, BALB/cByJ, BTBR T+
tf/tf
, C3H/HeJ, C57BL/6J, DBA/2J, and 
FVB/NJ) were tested for the acquisition and maintenance of ARR performance and the intralaboratory 
reliability of genetic differences. For animal husbandry information, see Supporting Text, which is published as 
supporting information on the PNAS web site, www.pnas.org. The ARR accelerated at a rate of 20 rpm/min. On 
two successive days, mice were given 10 trials on the rod with a 30-sec intertrial interval (ITI). For ethanol and 
acceleration rate studies, male and female mice (n = 6 per dose per strain) were trained with 10 consecutive 
trials at 20 rpm/min. The next day, mice were then given one trial on the rotarod at 20 rpm/min to reacquaint the 
mice with the apparatus, followed by five baseline trials, one each at 20, 30, 40, 50, and 60 rpm/min 
consecutively. Mice were then injected with 0, 1.0, 1.25, 1.5, 1.75, or 2.0 g/kg ethanol and placed in individual 
holding cages. Thirty minutes later, mice were tested again at 20, 30, 40, 50, and 60 rpm/min consecutively. 
After 48 h, mice were retested in a similar manner, except that mice were administered 0, 2.0, 2.25, 2.5, 2.75, or 
3.0 g/kg ethanol. Mice that received 0 or 2.0 g/kg on the first ethanol day were given the same dose on the 
second test day. All other mice were rerandomized to one of the four other dose groups. 
 
For interlaboratory reliability studies, male and female mice from 21 inbred strains (129S1/SvImJ, A/J, AKR/J, 
BALB/ cByJ, BTBR T+
tf/tf
, C3H/HeJ, C57BL/6J, C57L/J, C58/J, CAST/Ei, DBA/2J, FVB/NJ, MOLF/Ei, 
NOD/LtJ, NZB/ BINJ, PERA/Ei, PL/J, SJL/J, SM/J, SPRET/Ei, and SWR/J) were tested concurrently in 
Portland and Edmonton. Mice were trained with one day of 10 consecutive trials on the ARR at 20 rpm/min. 
The next day, mice were weighed and given three baseline trials, followed immediately by an injection of 
saline. After 30 min, mice were given three more tests and returned to the home cage. The next day, mice were 
treated identically, except that each mouse was injected with 2.0 g/kg (20% vol/vol) ethanol immediately after 
the three baseline trials, and tested 30 min later. 
 
FSRR. Eight inbred strains were tested for performance on the FSRR by using parameters determined from 
studies conducted with genetically heterogeneous mice (13). All mice were tested at 3, 6.5, and 10 rpm 
consecutively, with 72 h between tests. For each speed, mice were given three practice trials (30 sec maxi-mum, 
30 sec ITI) before being given a 3-min criterion test. As soon as a mouse passed one criterion test (or was tested 
a maximum of 10 times), it was injected with 1.0, 2.0, or 3.0 g/kg ethanol and immediately placed back on the 
rod. If mice were able to stay on the rod for 3 min after ethanol, they were removed and returned to their home 
cages. 
 
To compare with the ARR results another way, mice from the same eight inbred strains were tested on the 
FSRR 30 min after ethanol treatment. Mice were trained to perform on the rotarod at 3 and 6.5 rpm one day and 
10 rpm the following day. For each speed, mice were given three practice trials followed immediately by a 3-
min criterion test. As soon as a mouse passed the criterion test, it was returned to its home cage. Five days after 
training at 10 rpm, mice were tested again. On this day, mice were given three trials at 6.5 rpm, immediately 
injected with 1.25 or 1.75 g/kg ethanol, and tested 30 min later at 3, 6.5, and 10 rpm consecutively. Pilot studies 
showed that 2.0 g/kg was too high a dose for the majority of mice to be able to perform 30 min later. If mice 
were able to stay on the rod for 3 min after ethanol, they were given a score of ―pass‖ and taken off the rod. 
        
 
       
 
Results 
Sexes did not differ significantly, so all reported analyses are collapsed across sex. Testing on the ARR at an 
acceleration rate of 20 rpm/min revealed a significant learned component to the task (Table 1). Collectively, all 
strains improved over trials [F(9,711) = 59.8,P < 0.001] and days [F(1,79) = 65.0,P < 0.001]. Strains differed in 
their asymptotic performance on the ARR [F(7,79) = 31.8, P < 0.001], with BTBR T+
tf/tf
 performing markedly 
better than all of the rest. Strains also differed in their performance across trials [F(63,711) = 4.6, P < 0.001] 
and days [F(7,79) = 13.5, P < 0.001]. Genotypic test–retest reliability was determined by comparing strain 
means for the average of the last five trials on day 1 with the average of the last five trials on day 2. These strain 
means were correlated with a Pearson’s r = 0.97, showing that day 1 performance was highly predictive of 
performance on day 2. 
 
We next assessed the effect of ethanol dose and acceleration rate on ARR. Strains differed significantly in their 
ability to perform on the ARR at the end of training [F(7,263) = 28.2, P < 0.001]. Therefore, we sought an 
index of postethanol performance that would reflect both basal ability and sensitivity to ethanol. Both the 
change from baseline latency to fall after ethanol and the percent of baseline performance produced large and 
reliable genetic differences. Genotypic reliabilities were slightly higher when using the change from baseline, as 
were the effect sizes for strain when each dose and acceleration rate was analyzed. We therefore report ARR 
data as the change from baseline latency to fall after treatment (Table 2). 
 
 
 
It was clear from this experiment that the most robust strain and ethanol dose effects were seen at the slowest 
acceleration rate and that the fastest acceleration rate suppressed these differences (Fig. 1). There was a wide 
range of performance among strains when tested at 20 rpm/min; however, at 60 rpm/min, there was less 
variation among strains. Importantly, testing at the slower acceleration rate allowed detection of ethanol’s dose-
related effects, and low doses of ethanol improved performance over baseline in some strains. Higher doses of 
ethanol tended to impair performance across strains; however, there were a few strains (BALB/cByJ, FVB/NJ, 
and DBA/2J) that were not affected by the 2 g/kg dose. When tested at higher doses of ethanol (up to 3 g/kg) 48 
h later, these more resistant strains also showed impairment (data not shown). Strain differences in sensitivity to 
ethanol-enhanced performance were all but abolished at 60 rpm/min, as was the tendency for higher doses to 
impair performance strain-specifically. Blood ethanol concentrations (BEC) from the eight strains ruled out a 
pharmacokinetic explanation of strain sensitivity differences. Although strains differed in BEC [F(7,86) = 7.4, P 
< 0.001], strain means for BEC did not correlate with postethanol performance on the ARR (r = 0.19, not 
significant, data not shown). 
 
 
    
 
 
Using the information gained from the ethanol dose and acceleration rate experiment, 21 strains of mice were 
tested in two separate laboratories to assess inter- and intralaboratory genetic reliability of the ARR data. Strain 
performances were highly consistent both between and within laboratories (Fig. 2, Table 3). However, there 
were a few strains (BTBR T+
tf/tf
, AKR/J, and 129S1/SvImJ) that showed different acquisition of rotarod 
performance in Portland and Edmonton. These strains tended to acquire the task better in Edmonton. Even with 
these differences, interlaboratory correlations of strain means for peak acquisition performance after initial 
training (last two trials), presaline baseline, and preethanol baseline ranged from r = 0.69-0.80 (P < 0.01). 
Intralaboratory correlations were even higher, ranging from r = 0.80-0.95, suggesting the test is highly reliable 
for detecting the effects of genotype on undrugged performance. Sensitivity to 2.0 g/kg ethanol was also 
significantly correlated between laboratories (r = 0.49, P < 0.03; Fig. 3). When the wild-derived MOLF/Ei 
strain was removed from this analysis, the correlation increased to r = 0.69 (P < 0.01). 
 
      
 
The fixed-speed version of the rotarod task was tested in eight inbred strains. Results are shown in Fig. 4. At 
each rpm (3, 6.5, and 10), there was a significant effect of ethanol dose (F > 5.9, P < 0.01) with higher doses 
leading to shorter latencies to fall. At 3 and 6.5 rpm, there were also significant effects of strain (F > 3.12, P < 
0.01), but at 10 rpm, the effect of strain was suppressed (F = 1.51, not significant). We analyzed data only from 
those mice that were able to pass a 3-min criterion test before drug administration each day. This resulted in 
elimination of the A/J strain from the 6.5- and 10-rpm analyses because so few mice were able to pass the 
preinjection criterion test (2 of 23 mice passed at 10 rpm). 
 
We were interested in the genetic relationship between performance on the two versions of the rotarod task. To 
assess this, we correlated strain means for performance after 2 g/kg on the ARR (20 rpm/min) and the FSRR (3 
rpm). Higher strain sensitivity to ethanol on the ARR was correlated with lower sensitivity on the FSRR (r = —
0.54, not significant; Fig. 5A). Without the BTBR+
tf/tf
 strain, the correlation of performance became r = 0.18 
(not significant), suggesting virtually no genetic relationship between these traits. Because these two assays 
were performed at different times after ethanol administration (FSRR immediately and ARR at 30 min), we 
tested another sample of the same eight strains on the FSRR 30 min after injection, when stable brain ethanol 
levels make the FSRR a pass–fail test. Mice were tested after 1.75 g/kg, because pilot testing showed that 2 g/kg 
was too high for most strains to be able to perform the task 30 min later. The percentage of mice per strain that 
passed a 3-min test after ethanol on the FSRR correlated significantly with ARR performance after 1.75 g/kg (r 
= 0.87, P < 0.01; Fig. 5B). Even when excluding the BTBR T+
tf/tf
 strain, the correlation was still very high (r = 
0.75, P = 0.05). These analyses showed that there is a substantial shared genetic contribution in the two tasks, 
but only when they are used at the same postethanol time point. 
 
Discussion 
Our results illustrate the importance of using multiple task parameters when comparing different genotypes on 
the rotarod, as testing with a single set of parameters may lead to an inaccurate assessment of the true genotypic 
differences. One example of this is the effect of ethanol dose on ARR performance. Had we compared 
C57BL/6J with BALB/cByJ mice after a 1 g/kg dose of ethanol at 20 rpm/min, we would have concluded that 
they did not differ in ethanol sensitivity. However, after 2 g/kg, C57BL/6J mice were much more sensitive than 
BALB/cByJ mice. In addition, had we only tested strains at 2 g/kg ethanol, we would have missed the enhanced 
performance seen in many strains given low (1–1.25 g/kg) doses of ethanol (Fig. 1). 
 
It was also clear that the rotarod may not be the ideal test of ataxia or intoxication for certain genotypes because 
of their propensity to jump from the rod instead of running on top. This was observed often in BTBR T+
tf/tf
 and 
the wild-derived SPRET/Ei mice. In addition, some strains may be more prone to holding onto the rod and 
passively rotating around instead of actively performing the task. Previous reports have noted this behavior (8, 
16, 17), which we consider to be a different response that should be treated separately from balance and walking 
performance. We avoided this potential confound by using a rod diameter (6.3 cm) large enough to prevent the 
majority of mice from being able to hold on and rotate passively (13). 
 
Motor coordination (18), as well as motor learning (19, 20), are thought to require functional integration of 
frontoparietal and motor cortex, cerebellum, and striatal circuitry. It is not surprising to see differences in 
acquisition, retention, and peak rotarod performance among a set of inbred strains (Table 1, Fig. 2). These 
differences are likely to reflect differences in structure and/or function of these essential brain regions, and 
different neuronal sensitivity to ethanol in these brain regions may also explain the strain differences in ethanol-
induced ataxia. 
 
We encourage the use of the rotarod for future studies of motor incoordination in new genotypes such as null-
mutant mice, but recommend certain test parameters. We suggest using rotation rates no greater than 10 rpm for 
the FSRR and acceleration rates ≤30 rpm/min for the ARR. Intermediate acceleration rates produced graded 
results (data not shown), and the highest rates (≥40 rpm/min) reduced the sensitivity of the apparatus to detect 
strain and drug-dose effects. Future testing should use rod diameters of at least 6 cm to prevent mice from 
passively rotating on the rod instead of running on top. For intoxication studies, we recommend that mice be 
trained to a stable level of performance before drug administration. This insures that changes seen after drug 
administration are the result of drug action and not effects on learning on the apparatus. It also establishes that 
genetic differences in drug sensitivity are not confounded with genetic differences in undrugged performance. 
In our hands, 10 massed trials was sufficient to produce peak performance across 21 strains, but some 
genotypes may differ. We also recommend testing multiple drug doses. Although drugs were known to improve 
rotarod performance (3, 4), we were surprised to learn that low doses of ethanol could improve performance. 
Testing multiple doses can allow the detection of both increased and decreased performance on the ARR. 
 
Much has been made of the occasional inability of laboratories to reproduce findings of other laboratories (15). 
Perhaps one reason for this is that laboratories are often comparing behavior by using somewhat different 
apparatus and/or testing protocols. For example, the elevated plus maze, one of the more common tests of 
anxiety in rodents, differs frequently across laboratories in lighting conditions and in the wall height of the 
open, more anxiogenic portion of the maze, which affects alley selection of the subjects (21). Many different 
tests of learning and memory are used, often as if they were interchangeable, but genetic influence is likely to 
depend on specific parameters for these tests, too. Our studies show that procedural variables that may seem 
small to the experimenter can have pronounced effects on the pattern of genetic differences. The current set of 
experiments may represent a good strategy to improve interlaboratory reliability. By first identifying the most 
sensitive procedure for detecting genetic effects, we were able to detect highly reliable strain differences first 
within and then across our two laboratories (Fig. 3). By establishing the important procedural parameters of 
other behavioral tests of ataxia and tasks in other domains (e.g., anxiety and learning), we may be better 
positioned to design studies with maximal sensitivity to detect genetic differences. This should lead to more 
repeatable results both within and across laboratories. Even when such measures were taken, though, some 
laboratory-specific results were seen. The BTBR T+
tf/tf
, AKR/J, and 129S1/SvImJ strains acquired the ARR test 
differently in Portland and Edmonton (Fig. 2). The poor performance of the BTBR strain in Portland was a 
surprise. In our first experiment in Portland (Table 1), this strain performed more like those tested in Edmonton. 
One explanation for these differences is that for these two experiments in Portland, there were different 
experimenters. Experimenter effects have been shown to affect behavioral results in other tests (22). Further, 
BTBR mice were not present in each shipment of mice for the second experiment, so the observed site 
differences may have originated from differential shipping effects. We believe that there will always be some 
genetic results that are laboratory specific. Systematic studies can reveal some of the bases for such effects (22). 
 
Our data show the sensitivity of behavioral genetic results to specifics of the apparatus and protocol, and 
underscore the importance of adopting test parameters appropriate for a given experimental question. Further, 
they imply that more than a single test variant is required to characterize a complex behavioral domain, such as 
ataxia. Single variants of the rotarod task are often used to characterize targeted mutants, but such findings may 
not generalize widely. Systematic work with several genotypes and multiple tasks, each capturing different parts 
of the behavioral domain, will be necessary to understand the paths from behavioral assays through their 
component traits and biological substrates to specific genes. 
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